Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program Collaboration represents the first time the ACC's PINNACLE Registry Research Alliance will be used for clinical trial recruitment PARIS and TARRYTOWN, N.Y., Dec. 19, 2013 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
http://www.drugs.com/clinical_trials/sanofi-regeneron-cholesterol-deal-16403.html?
http://www.drugs.com/clinical_trials/sanofi-regeneron-cholesterol-deal-16403.html?
No comments:
Post a Comment